Abstract
IntroductionPeople with advanced non-small cell lung cancer (NSCLC) treated with immunotherapies (IT) or targeted therapies (TT) may have improved outcomes in a subset of people who respond, raising unique psychological...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have